Skip to Content


In the US, Infliximab (infliximab systemic) is a member of the following drug classes: antirheumatics, TNF alfa inhibitors and is used to treat Ankylosing Spondylitis, Behcet's Disease, Bullous Pemphigoid, Celiac Disease, Cogan's Syndrome, Crohn's Disease, Crohn's Disease - Acute, Crohn's Disease - Maintenance, Giant Cell Arteritis, Inflammatory Bowel Disease, Juvenile Idiopathic Arthritis, Kawasaki Disease, Neurosarcoidosis, Pemphigoid, Pemphigus, Plaque Psoriasis, Polychondritis, Psoriasis, Psoriatic Arthritis, Pulmonary Fibrosis, Pyoderma Gangrenosum, Rheumatoid Arthritis, SAPHO Syndrome, Sarcoidosis, Sjogren's Syndrome, Spondyloarthritis, Subcorneal Pustular Dermatosis, Toxic Epidermal Necrolysis, Ulcerative Colitis, Ulcerative Colitis - Maintenance and Uveitis.

US matches:



ATC (Anatomical Therapeutic Chemical Classification)


CAS registry number (Chemical Abstracts Service)


Chemical Formula


Molecular Weight


Therapeutic Categories

Anti-inflammatory agent

Disease-modifying antirheumatic drug, DMARD

Biological response modifier, BRM


Monoclonal antibody

Tumor necrosis factor alpha (TNF-α) inhibitor

Chemical Name

Immunglobulin G (human-mouse monoclonal cA2 heavy chain anti-human tumor necrosis factor), disulfide wit human-mouse monoclonal cA2 light chain, dimer (WHO)

Foreign Names

  • Infliximabum (Latin)
  • Infliximab (German)
  • Infliximab (French)
  • Infliximab (Spanish)

Generic Names

Brand Names

  • Flammegis
    Celltrion, Georgia
  • Inflectra
    Alvogen, Croatia (Hrvatska); Celltrion Inc, United States; Hospira, Austria; Hospira, Bosnia & Herzegowina; Hospira, Belgium; Hospira, Switzerland; Hospira, Germany; Hospira, Spain; Hospira, France; Hospira, Iceland; Hospira, Norway; Hospira, Poland; Hospira, Romania; Hospira, Slovenia; Hospira, Slovakia; Hospira UK, United Kingdom
  • Remicade
    Bayer, Egypt; Centocor, Lithuania; Centocor, United States; Essex, Lebanon; Janssen, Canada; Janssen, Chile; Janssen, Hong Kong; Janssen, Hungary; Janssen, Iceland; Janssen, Malaysia; Janssen, Norway; Janssen, New Zealand; Janssen, Romania; Janssen, Singapore; Janssen, Thailand; Janssen Bio, Netherlands; Janssen Biologics, Austria; Janssen Biologics, Greece; Janssen Biologics B.V., Serbia; Janssen Cilag, Argentina; Janssen-Cilag, Colombia; Janssen-Cilag, Czech Republic; Janssen-Cilag, Israel; Janssen-Cilag, Mexico; Janssen-Cilag, Poland; Janssen-Cilag, Tunisia; Janssen-Cilag, Vietnam; Merck Sharp & Dohme, Bosnia & Herzegowina; Merck Sharp & Dohme, Spain; Merck Sharp & Dohme, United Kingdom; MSD, Switzerland; MSD, Denmark; MSD, Finland; MSD, Ireland; MSD, Peru; MSD, Sweden; MSD Belgium, Belgium; MSD France, France; MSD Merck Sharp & Dohme, Germany; MSD Merck Sharp & Dohme, Turkey; Schering-Plough, Italy; Schering-Plough, Latvia; Schering-Plough, Oman; Schering-Plough, Portugal; Schering-Plough, Russian Federation; Schering-Plough, Slovakia; Tanabe, Indonesia; Tanabe Mitsubishi Pharma, Japan; Xian Janssen, China
  • Remsima
    Biogaran, France; Biotec Services International, Bosnia & Herzegowina; Celltrion, South Korea; Celltrion, Norway; Celltrion, Romania; Celltrion, Slovenia; Celltrion Healthcare Hungary, Poland; Egis, Latvia; Egis, Slovakia; iQone, Switzerland; Kern, Spain; Mundipharma, Belgium; Napp Pharmaceuticals, United Kingdom; Oktal, Croatia (Hrvatska); Orion Pharma, Finland
  • Revellex
    Janssen, South Africa


BANBritish Approved Name
DCFDénomination Commune Française
ISInofficial Synonym
JANJapanese Accepted Name
OSOfficial Synonym
Rec.INNRecommended International Nonproprietary Name (World Health Organization)
USANUnited States Adopted Name
WHOWorld Health Organization

Further information on drug naming conventions: International Nonproprietary Names.

Important Notice: The international database is in BETA release. This means it is still under development and may contain inaccuracies. It is not intended as a substitute for the expertise and judgement of your physician, pharmacist or other healthcare professional. It should not be construed to indicate that the use of any medication in any country is safe, appropriate or effective for you. Consult with your healthcare professional before taking any medication.

Further information

Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.